Akhondzadeh S - Search Results

1

Next generation sequencing: implications in personalized medicine and pharmacogenomics.

Rabbani B, Nakaoka H, Akhondzadeh S, Tekin M, Mahdieh N. Rabbani B, et al. Among authors: akhondzadeh s. Mol Biosyst. 2016 May 24;12(6):1818-30. doi: 10.1039/c6mb00115g. Mol Biosyst. 2016. PMID: 27066891 Review.

2

Herbal medicine in the treatment of Alzheimer's disease.

Akhondzadeh S, Abbasi SH. Akhondzadeh S, et al. Am J Alzheimers Dis Other Demen. 2006 Mar-Apr;21(2):113-8. doi: 10.1177/153331750602100211. Am J Alzheimers Dis Other Demen. 2006. PMID: 16634467 Free PMC article. Review.

3

Advances in Alternative and Integrative Medicine in the Treatment of Depression: A Review of the Evidence.

Shamabadi A, Akhondzadeh S. Shamabadi A, et al. Among authors: akhondzadeh s. Arch Iran Med. 2021 May 1;24(5):409-418. doi: 10.34172/aim.2021.59. Arch Iran Med. 2021. PMID: 34196207 Free article. Review.

4

Integrating Psychiatry and Medical Biotechnology as a Way to Achieve Scientific, Precision, and Personalized Psychiatry.

Shamabadi A, Hasanzadeh A, Akhondzadeh S. Shamabadi A, et al. Among authors: akhondzadeh s. Avicenna J Med Biotechnol. 2021 Oct-Dec;13(4):172-175. Avicenna J Med Biotechnol. 2021. PMID: 34900142 Free PMC article. Review.

5

Cardiovascular effects of saffron: an evidence-based review.

Kamalipour M, Akhondzadeh S. Kamalipour M, et al. Among authors: akhondzadeh s. J Tehran Heart Cent. 2011 Spring;6(2):59-61. Epub 2011 May 31. J Tehran Heart Cent. 2011. PMID: 23074606 Free PMC article.

6

More ACTIONS needed to reach a consensus on adjunctive antidepressant therapy for negative symptoms of schizophrenia.

Akhondzadeh S, Moazen-Zadeh E. Akhondzadeh S, et al. Evid Based Ment Health. 2017 Feb;20(1):e3. doi: 10.1136/eb-2016-102500. Epub 2016 Dec 23. Evid Based Ment Health. 2017. PMID: 28011708 Free PMC article. No abstract available.

7

Melatonin for Reducing Weight Gain Following Administration of Atypical Antipsychotic Olanzapine for Adolescents with Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.

Mostafavi SA, Solhi M, Mohammadi MR, Akhondzadeh S. Mostafavi SA, et al. Among authors: akhondzadeh s. J Child Adolesc Psychopharmacol. 2017 Jun;27(5):440-444. doi: 10.1089/cap.2016.0046. Epub 2017 Mar 24. J Child Adolesc Psychopharmacol. 2017. PMID: 28339282 Clinical Trial.

8

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Akhondzadeh S, et al. J Clin Pharm Ther. 2003 Feb;28(1):53-9. doi: 10.1046/j.1365-2710.2003.00463.x. J Clin Pharm Ther. 2003. PMID: 12605619 Clinical Trial.

9

Alzheimer's disease: pathophysiology and pharmacotherapy.

Akhondzadeh S, Noroozian M. Akhondzadeh S, et al. IDrugs. 2002 Nov;5(11):1062-9. IDrugs. 2002. PMID: 12800059

10

Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial.

Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. Akhondzadeh S, et al. J Neurol Neurosurg Psychiatry. 2003 Jul;74(7):863-6. doi: 10.1136/jnnp.74.7.863. J Neurol Neurosurg Psychiatry. 2003. PMID: 12810768 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page